Clinical Trial Update: A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase I study of BMS-641988 in Japanese patients with castration-resistant prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• BMS-641988

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED